目的 探討大腸癌患者外周血CK20 mRNA的表達及其意義。
方法 用逆轉(zhuǎn)錄-聚合酶鏈反應(yīng)(RT-PCR)方法檢測42例大腸癌患者術(shù)前、術(shù)后外周血及20例大腸癌患者新鮮癌組織標(biāo)本中CK20 mRNA的表達,另以20例健康成年自愿者作對照。
結(jié)果 42例大腸癌患者外周血CK20 mRNA呈陽性表達者術(shù)前為19例(45.24%),術(shù)后為14例(33.33%); 20例大腸癌患者新鮮癌組織中CK20 mRNA表達均為陽性。而正常對照組20例外周血CK20 mRNA表達均為陰性。且大腸癌外周血CK20 mRNA陽性表達與組織學(xué)類型無關(guān)(P gt;0.05),但與有無淋巴結(jié)轉(zhuǎn)移、肝轉(zhuǎn)移及Dukes分期有關(guān)(P<0.05)。
結(jié)論 檢測外周血中CK20 mRNA表達將有助于大腸癌的早期診斷、預(yù)后的判斷及治療方案的制定。
引用本文: 孫建偉,華映坤,賈玲,林人龍,楊昆憲,陳居敏. 大腸癌患者外周血CK20 mRNA的表達及其意義. 中國普外基礎(chǔ)與臨床雜志, 2004, 11(2): 119-121. doi: 復(fù)制
版權(quán)信息: ?四川大學(xué)華西醫(yī)院華西期刊社《中國普外基礎(chǔ)與臨床雜志》版權(quán)所有,未經(jīng)授權(quán)不得轉(zhuǎn)載、改編
1. | Burchill SA, Bradbury MF, Pittman K, et al. Detection of epithelial cancer cells in peripheral blood by reverse transcriptasepolymerase chain reaction [J]. Br J Cancer, 1995; 71(2)∶278. |
2. | Bustin SA, Gyselman VG, Williams NS, et al. Detection of cytokeratins 19/20 and guanylyl cyclase C in peripheral blood of colorectal cancer patients [J]. Br J Cancer, 1999; 79(11-12)∶1813. |
3. | Peck K, Sher YP, Shih JY, et al. Detection and quantitation of circulating cancer cells in the peripheral blood of lung cancer patients [J]. Cancer Res, 1998; 58(13)∶2761. |
4. | Aihara T, Noguchi S, Ishikawa O, et al. Detection of pancreatic and gastric cancer cells in peripheral and portal blood by amplification of keratin 19 mRNA with reverse transcriptasepolymerase chain reaction [J]. Int J Cancer, 1997; 72(3)∶408. |
5. | Datta YH, Adams PT, Drobyski WR, et al. Sensitive detection of occult breast cancer by the reversetranscriptase polymerase chain reaction [J]. J Clin Oncol, 1994; 12(3)∶475. |
6. | Heiss MM, Allgayer H, Gruetzner KU, et al. Individual development and uPAreceptor expression of disseminated tumour cells in bone marrow: a reference to early systemic disease in solid cancer [J]. Nat Med, 1995; 1(10)∶1035. |
7. | Gala JL, Loric S. Sensitivity of specificity of reverse transcriptasepolymerase chain reaction assays: the real challenge for molecular staging of prostatic carcinomas [J]. Int J Cancer, 1998; 77(1)∶161. |
8. | Wolfgang H, Stefan A, Loening. Detection of illegitimate transcripts of prostatespecific antigen mRNA in blood by reverse transcriptionpolymerase chain reaction [J]. Int J cancer, 1998; 77(1)∶164. |
9. | 駱成玉,李世擁. 大腸癌患者外周血癌細胞檢測臨床意義 [J]. 中華實驗外科雜志, 1999; 16(3)∶19. |
- 1. Burchill SA, Bradbury MF, Pittman K, et al. Detection of epithelial cancer cells in peripheral blood by reverse transcriptasepolymerase chain reaction [J]. Br J Cancer, 1995; 71(2)∶278.
- 2. Bustin SA, Gyselman VG, Williams NS, et al. Detection of cytokeratins 19/20 and guanylyl cyclase C in peripheral blood of colorectal cancer patients [J]. Br J Cancer, 1999; 79(11-12)∶1813.
- 3. Peck K, Sher YP, Shih JY, et al. Detection and quantitation of circulating cancer cells in the peripheral blood of lung cancer patients [J]. Cancer Res, 1998; 58(13)∶2761.
- 4. Aihara T, Noguchi S, Ishikawa O, et al. Detection of pancreatic and gastric cancer cells in peripheral and portal blood by amplification of keratin 19 mRNA with reverse transcriptasepolymerase chain reaction [J]. Int J Cancer, 1997; 72(3)∶408.
- 5. Datta YH, Adams PT, Drobyski WR, et al. Sensitive detection of occult breast cancer by the reversetranscriptase polymerase chain reaction [J]. J Clin Oncol, 1994; 12(3)∶475.
- 6. Heiss MM, Allgayer H, Gruetzner KU, et al. Individual development and uPAreceptor expression of disseminated tumour cells in bone marrow: a reference to early systemic disease in solid cancer [J]. Nat Med, 1995; 1(10)∶1035.
- 7. Gala JL, Loric S. Sensitivity of specificity of reverse transcriptasepolymerase chain reaction assays: the real challenge for molecular staging of prostatic carcinomas [J]. Int J Cancer, 1998; 77(1)∶161.
- 8. Wolfgang H, Stefan A, Loening. Detection of illegitimate transcripts of prostatespecific antigen mRNA in blood by reverse transcriptionpolymerase chain reaction [J]. Int J cancer, 1998; 77(1)∶164.
- 9. 駱成玉,李世擁. 大腸癌患者外周血癌細胞檢測臨床意義 [J]. 中華實驗外科雜志, 1999; 16(3)∶19.